Jia Dan

Ms. Jia Dan


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2025 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
JDJia Dan
Jia Dan
YTYan Tang
Yan Tang
YLYin Liu
Yin Liu
YZYuping Zeng
Yuping Zeng
MZMei Zhang
Mei Zhang

13 August 2024 in Journal of Diabetes & Metabolic Disorders
Verified
Journal Article
Closed access
PDF file
ZWZhenpeng Wang
Zhenpeng Wang
MZMei Zhang
Mei Zhang
JDJia Dan
Jia Dan

20 March 2026
Verified
Journal Article
Open access
PDF file
JDJia Dan
Jia Dan
振王振棚 王
振棚 王
玫张玫 张
玫 张
目的

系统性筛选循环炎症蛋白(circulating inflammatory proteins, CIPs)中影响骨质疏松症(osteoporosis, OP)和骨折的潜在靶点,通过临床样本验证其与骨密度(bone mineral density, BMD)的关联,为骨代谢调控提供新靶点证据。

方法

利用双向孟德尔随机化分析CIPs与OP和骨折的因果关系。纳入2型糖尿病(type 2 diabetes mellitus, T2DM)和健康人群,收集患者一般资料,检测并比较合并OP的T2DM组(DOP)、无OP的T2DM组(NDOP)及对照组的成纤维细胞生长因子21(fibroblast growth factor 21, FGF21)与骨代谢指标。

结果

EBI GWAS Catalog数据库中获取的共91种CIPs中,逆方差加权(inverse variance weighting, IVW)分析显示FGF21同时与OP和过去5年发生骨折存在潜在因果关系,其水平升高增加OP风险〔比值比(odds ratio, OR)=1.003,95%置信区间(confidence interval, CI):1.001~1.005;P=0.004〕和过去5年发生骨折风险(OR=1.004,95%CI:1.000~1.008;P=0.038),反向MR显示OP和过去5年发生骨折对正向分析中确定的FGF21在内的8种CIPs没有因果影响。临床研究显示:DOP组血浆FGF21〔396.92 (308.98,523.94) pg/mL〕高于NDOP组〔346.88(283.82,466.86) pg/mL〕和对照组〔233.66(169.95,327.78) pg/mL〕(均P<0.05)。在全部样本中,调整年龄、体质量指数、糖化血红蛋白、钙和磷后,FGF21与腰椎(β=-0.003,95%CI:-0.004~-0.002,P<